Aditi Sharma

Study of the Serum Levels of C-Reactive Proteins as an Indicator of Disease Activity in Pulmonary Tuberculosis and Monitoring Response to Treatment

R. Sandhu, Raman Sharma, Rahul Sharma, 2016 .

Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis

M. Benatar, M. Bromberg, M. Pasnoor, 2020, JAMA neurology.

Potent preclinical sensitivity to imipridone-based combination therapies in oncohistone H3K27M-mutant diffuse intrinsic pontine glioma is associated with induction of the integrated stress response, TRAIL death receptor DR5, reduced ClpX and apoptosis.

W. El-Deiry, Lanlan Zhou, N. Tapinos, 2021, American journal of cancer research.

Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study.

R. Conwit, M. Benatar, D. Hafler, 2021, Neurology.

Differential response to rituximab in anti-AChR and anti-MuSK positive myasthenia gravis patients: a single-center retrospective study

V. Njike, B. Roy, R. Nowak, 2020, Journal of the Neurological Sciences.

Exploring outcomes and characteristics of myasthenia gravis: Rationale, aims and design of registry – The EXPLORE-MG registry

B. Roy, K. O’Connor, R. Nowak, 2020, Journal of the Neurological Sciences.

High-throughput investigation of molecular and cellular biomarkers in NMOSD

Terry J. Smith, M. Yeaman, K. O’Connor, 2020, Neurology: Neuroimmunology & Neuroinflammation.

DRESS SYNDROME: (Drug, Rash, Eosinophilia and Systemic Symptoms) - The Hypersensitivity Reaction due to Antipsychotic Drug - Quetiapine, the Pictorial Presentation

Raman Sharma, T. Sikri, N. Sharma, 2015 .